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The murine cytomegalovirus (MCMV) polymerase processivity factor ppM44 (also referred to as pp50) is an abundant
phosphoprotein found in MCMV-infected cells. Sequence analysis of the MCMV M44 open reading frame revealed an “RGD”
motif that is also present in the human cytomegalovirus (HCMV) UL44 open reading frame. In this report, histidine-tagged
M44 protein produced in Escherichia coli or the vaccinia/T7 expression system was purified to near homogeneity by metal
chelation affinity chromatography using His*Bind resins. We demonstrated that recombinant M44 protein could mediate cell
adhesion via its conserved “RGD” motif, because a single amino acid change (RGD to RGE) abolished cell attachment. In
addition, cell adhesion was abolished in the presence of EDTA. We next showed that recombinant HCMV UL44, but not human
herpesvirus type 6 p41, which lacks the RGD motif, could mediate cell adhesion in a similar manner. We also provided
evidence that ppM44 was present in the culture medium during virus infection. Thus these results suggested that in addition
to its primary role as the polymerase processivity factor, MCMV ppM44 may serve as a substrate for integrin-binding via its
conserved RGD motif, with the potential for a novel role in the MCMV replication cycle. © 2000 Academic Press
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5INTRODUCTION
Integrins constitute a widely expressed family of cell
surface adhesion molecules that mediate cell–cell asso-
ciation as well as interactions between cells and extra-
cellular matrix proteins (Hynes, 1987). These het-
erodimeric transmembrane receptors are made up of an
a chain and a b chain that associate noncovalently
Hynes, 1987). Sixteen a chains and eight b chains have
been identified in mammalian cells. Although the major-
ity of a chains associate with a single b chain, the b1, b2,
and b3 subfamilies of receptors can associate with mul-
tiple a chains, thereby generating at least 22 cell surface
receptors (Brodt and Dedhar, 1996). Although integrins
have been shown to recognize a number of different
sequences within extracellular ligands, a significant
number of these receptors recognize the Arg-Gly-Asp
(RGD) sequence, which is present in fibronectin, laminin,
type I collagen, and vitronectin (Loike et al., 1991; Pier-
chbacher and Ruoslahti, 1984; Ruoslahti and Piersch-
acher, 1987).
In recent years, there has been considerable interest
n the role of integrins in intracellular signaling (Giancotti
nd Ruoslahti, 1999). Although their short cytoplasmic
ails lack intrinsic enzymatic activity, integrins can be
inked to signal transduction pathways via their associ-
tion with adapter proteins that connect them to theT
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302cytoskeleton, cytoplasmic kinases, and transmembrane
growth factor receptors. Thus integrins have been shown
to play a dual role, mediating “outside-in” signaling
events after binding to extracellular matrix components
as well as responding to intracellular signals (“inside-
out” signaling) (Giancotti, 1997).
The ubiquitous presence of integrin molecules on the
cell surface makes them attractive candidates for medi-
ating virus entry into susceptible host cells. For example,
the RGD sequence on the VP1 protein of foot-and-mouth
disease virus is involved in virus attachment to integrin
receptors (Fox et al., 1989). The adenovirus penton base
rotein also contains an RGD sequence that can mediate
ell adhesion and has been implicated in cell-rounding
ctivity as well as virus entry (Bai et al., 1993; Belin and
oulanger, 1993). More intriguing is the observation that
he RGD sequence in the HIV-1 tat protein could mediate
ell adhesion (Brake et al., 1990) even though it is nor-
ally resident in the nucleus. One hypothesis stated that
he ability of tat to bind integrin molecules could promote
ts uptake into latently infected cells, where transactiva-
ion of latent virus might occur. Thus viral proteins pos-
essing an RGD sequence could potentially use their
ntegrin binding activity to benefit the virus.
The murine cytomegalovirus (MCMV) polymerase acces-
ory protein ppM44 (previously referred to as pp50) is an
bundantly expressed phosphoprotein of molecular weight
0,000 found in MCMV-infected fibroblasts (Loh et al., 1991).
he protein is encoded by the M44 open reading frame
ORF) (Loh et al., 1994; Rawlinson et al., 1996), which shares
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303RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEINsignificant amino acid sequence homology with the human
cytomegalovirus (HCMV) UL44 (Chee et al., 1990; Mocarski
et al., 1985) and human herpesvirus type 6 (HHV-6) p41
proteins (Chang et al., 1991). Sequence alignments re-
vealed two highly conserved blocks of amino acids encom-
passing the N-terminal two thirds of the molecule and two
shorter stretches of conserved amino acid residues within
the much more variable C-terminal tail (Fig. 1). Like its
HCMV and HHV-6 counterparts (Agulnick et al., 1993; Wei-
land et al., 1994), MCMV ppM44 is a DNA-binding protein
and appears to associate with multiple viral proteins in
infected cells (Loh et al., 1994). In addition, both MCMV
ppM44 and HCMV ppUL44 localize to nuclear replication
compartments during virus infection of permissive fibro-
blasts (Penfold and Mocarski, 1997; Loh et al., manuscript
in preparation) and possess a stretch of basic amino acids
near the end of the C-terminal tail that acts as a nuclear
localization signal (Loh et al., 1999). Other than its primary
function as the polymerase processivity factor (Ertl and
Powell, 1992), no other role in the CMV life cycle has been
ascribed to these two viral proteins. Interestingly, an “RGD”
motif is conserved between the HCMV UL44 and MCMV
M44 ORFs (Fig. 1), suggesting that both proteins may serve
as substrates for integrin-binding and cell adhesion.
In this report, we attached a 6x histidine tag to the
N-terminus of the M44 protein to facilitate its purification
by metal chelation affinity chromatography. The recom-
binant protein was initially produced in Escherichia coli
and later in a vaccinia/T7 expression system in amounts
sufficient for conducting cell adhesion assays. Our re-
FIG. 1. An “RGD” motif is located within conserved region 2 of the MCMV
M44 ORF. The first line represents a sequence ruler with tick marks every
20 amino acids along the entire length of the M44 ORF. The M44 ORF is
represented underneath as four highly conserved blocks of amino acid
residues (between MCMV, HCMV, and HHV-6) with appropriate residue
numbers either below or above the numbered blocks. Locations for the
RGD motif and the previously mapped nuclear localization signal are
shown. The aligned amino acid sequences surrounding the RGD motif are
shown for all three viruses in the area immediately below.sults suggested that both the M44 and UL44 proteins
could mediate cell adhesion via the RGD motif.RESULTS
Purified M44 protein is a substrate for cell adhesion
To evaluate whether ppM44 can act as a substrate for
integrin binding, recombinant M44 protein was produced
in E. coli and purified on His*Bind resin as described
under Materials and Methods. As shown in Fig. 2A, a
single prominent band with an apparent molecular
weight of about 55,000 (lane 1) was present in the pooled
eluted protein fraction. In a Western blot, the purified
protein was reactive with a ppM44-specific monoclonal
antibody (MAb) 3B9.22A (lane 2), indicating that it corre-
sponds to the histidine-tagged M44 protein.
As shown in Fig. 3A, wells of a PolySorp plate coated
with purified M44 protein at concentrations higher than
2.5 mg/ml were able to mediate adhesion of CV-1 cells.
owever, adhesion was reduced to background levels
hen cells were incubated in the presence of RGD
eptides (250 mg/ml) or 10 mM EDTA but not in the
resence of RGE peptides of similar concentrations (Fig.
B). When viewed under a microscope, wells that
howed the highest optical density readings were cov-
red with a monolayer of adherent cells. As the optical
ensity readings decreased, fewer and fewer cells re-
ained attached to the bottom of the wells. Control wells
oated only with bovine serum albumin (BSA) were vir-
ually devoid of cells. Thus the optical density readings
orrelated with cell adhesion, and our results suggested
hat the M44 protein mediated cell adhesion via the RGD
equence located at residues 276–278. Coupled with the
equirement for divalent cations as evidenced by the lack
f cell adhesion in the presence of EDTA, our observa-
ions are compatible with the hypothesis that the M44
ene product can act as a substrate for integrin binding.
In parallel with our experiments with purified M44
rotein, cell adhesion experiments were conducted with
ther RGD-containing protein substrates such as fi-
ronectin, laminin 1, collagen I, and entactin–nidogen
Mann et al., 1989; Ruoslahti and Pierschbacher, 1987;
FIG. 2. Analysis of purified recombinant M44, HCMV UL44, and
HHV-6 p41 proteins by silver staining and Western blotting. Recombi-
nant M44 (A), HHV-6 p41 (B), and HCMV UL44 (C) proteins purified by
His*Bind resin as described under Materials and Methods were sep-
arated by SDS–PAGE and visualized by silver staining (lane 1, all
panels). Alternatively, proteins separated by SDS–PAGE were trans-
ferred to nitrocellulose membranes and visualized by their reactivities
with monoclonal antibodies specific for each of the herpesvirus poly-
merase accessory proteins by Western blotting (lane 2, all panels). The
monoclonal antibodies used are 3B9.22A (A), 9A5 (B), and 28-21 (C).
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304 LOH ET AL.Sonnenberg et al., 1990). As shown in Fig. 3, these
ubstrates differed in their ability to mediate adhesion by
V-1 cells and their sensitivity to inhibition by the RGD
eptide GRGDSP. For example, the adhesive property of
pM44 is similar to that of fibronectin, because the ac-
ivities of both were significantly inhibited by the RGD
eptide (Fig. 3B). In contrast, laminin 1 and entactin were
FIG. 3. Purified M44 protein could mediate adhesion of CV-1 cells. (A
ith different concentrations of RGD-containing proteins as described
ere purchased commercially, whereas the histidine-tagged M44 prote
readings at 600 nm (OD600) were used to quantify the amount of toluidine
deviation for each data point were shown only for ppM44. (B) Cell a
fibronectin, collagen I, and histidine-tagged M44 protein at concentrati
The effects of RGD and RGE peptides (at final concentrations of 250 m
ut the assays in the presence of these inhibitors. As negative contro
erum albumin (BSA) at 10 mg/ml.ery poor substrates for CV-1 adhesion (Fig. 3A), and in
greement with a previous report (Dedhar et al., 1987),
a
hollagen I-mediated adhesion was inhibited only mini-
ally by the RGD peptide GRGDSP (Fig. 3B). Thus the
resence of an RGD sequence in a protein substrate is
ot sufficient for mediating efficient cell adhesion to CV-1
ibroblasts.
We next carried out cell adhesion assays with Balb/
T3 fibroblasts to assess whether the M44 protein can
dhesion assays were carried out with wells of PolySorp plates coated
aterials and Methods. Fibronectin, laminin 1, collagen I, and entactin
purified from E. coli harboring the plasmid pRsetBpp50. Optical density
tain extracted from adherent cells. Error bars representing the standard
n assays were conducted with wells of PolySorp plates coated with
10 mg/ml or with laminin 1 and entactin at concentrations of 50 mg/ml.
s well as EDTA (10 mM) on cell adhesion were assessed by carrying
adhesion assays were also carried out with wells coated with bovine) Cell a
under M
in was
blue s
dhesio
ons of
g/ml) also mediate attachment of cells derived from the natural
ost of MCMV. As shown in Fig. 4A, although Balb/3T3
i305RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEINfibroblasts did attach to wells coated with M44, it did not
attach with the same efficiency as CV-1 cells. For exam-
ple, significant attachment occurred only if wells were
coated with M44 protein at a concentration greater than
10 mg/ml. Again, cell adhesion was abolished in the
presence of RGD peptides but not in the presence of
RGE peptides (Fig. 4B). Because of the higher readings
and, hence, increased sensitivity we obtained with CV-1
cells, most of our cell adhesion assays were carried out
with that cell line.
A single amino acid change (RGD to RGE) abolishes
cell adhesion
To provide additional proof that the RGD sequence of
M44 is responsible for mediating cell adhesion, the as-
partic acid at residue 278 was changed to a glutamic
acid by site-directed mutagenesis to create the mutant
M44D278E protein. Both wild-type (wt) and mutant forms
of the histidine-tagged M44 protein were produced in E.
FIG. 4. Purified M44 protein could mediate adhesion of Balb/3T3
fibroblasts. Cell adhesion assays were carried out with wells of Poly-
Sorp plates coated with different concentrations of purified histidine-
tagged M44 protein as described under Materials and Methods. Opti-
cal density readings at 600 nm (OD600) were used to quantify the
amount of toluidine blue stain extracted from adherent cells (A). (B) The
effect of RGD and RGE peptides (both at 500 mg/ml) on cell adhesion
was assessed. Other than the “BSA” wells, which were coated with only
bovine serum albumin, all other wells (including the “control” wells)
were coated with 100 ml of purified M44 protein at a concentration of 15
mg/ml.coli and purified by His*Bind resin to near homogeneity
(data not shown).To alleviate concerns that the single amino acid sub-
stitution may alter the conformation of the protein, we
conducted an ELISA with a monoclonal antibody that is
sensitive to changes in the conformation of the protein.
We have previously shown that MAb 9A5 recognizes a
conformation-dependent epitope that is extremely sensi-
tive to alterations within conserved region 2 of the M44
protein (Loh et al., 1999). As shown in Table 1, this
antibody was reactive with M44 and M44D278E proteins
to similar extents. Thus our results suggested that the
RGD-to-RGE mutation did not significantly alter the con-
formation of M44 around conserved region 2 where the
RGD sequence is located. Furthermore, while the recom-
binant protein was allowed to refold by stepwise removal
of urea (see section on metal chelation affinity chroma-
tography under Materials and Methods), it has at least
achieved a conformation sufficiently similar to ppM44
that reactivity with MAb 9A5 was restored.
As seen in our previous experiments, the wt M44
protein mediated adhesion by CV-1 cells in a concentra-
tion-dependent manner (Fig. 5). However, cells did not
remain attached in wells coated with the mutant
M44D278E protein. Thus our results demonstrated that
an intact RGD sequence is required for mediating cell
adhesion.
HCMV UL44, but not HHV-6 p41, is a substrate for
cell adhesion
Because the RGD sequence is conserved between
HCMV UL44 and MCMV M44 ORFs and absent in HHV-6
p41, we decided to investigate whether our findings with
the M44 protein could be extended to the HCMV ho-
molog. To this end, the histidine-tagged UL44 and p41
proteins were produced in E. coli and purified on
His*Bind resin as described under Materials and Meth-
ods. In each instance, the fusion protein was present as
a single prominent band after SDS–PAGE (Figs. 2B and
TABLE 1
Reactivity of Recombinant Protein with MAb 9A5 in ELISA
Proteina
(mg/well)
Reactivity with
M44 (OD405)
b
Reactivity with
M44D278E
(OD405)
b
2 0.38 6 0.01 0.36 6 0.01
0.5 0.26 6 0.02 0.28 6 0.02
0.1 0.15 6 0.00 0.17 6 0.00
0.01 0.14 6 0.006 0.15 6 0.01
0c 0.13 6 0.01 0.13 6 0.01
a Wells were coated overnight at 4°C with the amount of protein
ndicated in the presence of 0.25 M urea.
b An ELISA was carried out as described in Materials and Methods
with MAb 9A5 (1:5000) as the first antibody. Reactivity was quantified by
reading the optical density at 405 nm.
c Wells were coated with BSA only.
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306 LOH ET AL.2C, lane 1) that is recognized by a monoclonal antibody
specific for the authentic viral protein (Figs. 2B and 2C,
lane 2).
As shown in Fig. 6, CV-1 cells were able to attach to
wells coated with HCMV UL44 in a concentration-depen-
dent manner but not to those coated with HHV-6 p41.
Moreover, adhesion to wells coated with the UL44 pro-
tein is sensitive to the presence of EDTA and inhibited by
RGD peptides but much less affected by RGE peptides.
Therefore, our results suggested that the HCMV UL44
protein, like its MCMV homolog, can mediate the attach-
ment of CV-1 cells via its RGD sequence.
MCMV M44 protein produced in a vaccinia/T7
expression system can mediate cell adhesion
Up to this point, the recombinant proteins used for cell
adhesion assays were produced in E. coli and lacked the
osttranslational modifications commonly found in an
ukaryotic environment. We previously reported that
pM44 (also known as pp50) is highly phosphorylated
Loh et al., 1991) and may contain disulfide linkages (Loh
t al., 1994). In addition, we demonstrated that ppM44
roduced in recombinant vaccinia virus (VVpp50)-in-
ected cells is identical to that synthesized in MCMV-
nfected cells (Loh et al., 1994). Therefore, we decided to
nvestigate whether recombinant histidine-tagged
pM44 produced in a vaccinia/T7 expression system
Fuerst et al., 1986) could mediate cell adhesion. To this
nd, recombinant ppM44 protein produced in CV-1 cells
ransfected with the plasmid pRsetBpp50 and infected
FIG. 5. A single amino acid change (RGD to RGE) in the M44 protein
abolishes its ability to mediate cell adhesion. Cell adhesion assays
were carried out with wells of PolySorp plates coated with different
concentrations of either the histidine-tagged M44 protein or the histi-
dine-tagged M44D278E mutant protein in the presence of 0.25 M urea
as described under Materials and Methods. Optical density readings at
600 nm (OD600) were used to quantify the amount of toluidine blue stain
xtracted from adherent cells.ith VV-T7 was purified on His*Bind resin as described
nder Materials and Methods. The pooled fractions ofeluted ppM44 contained a single prominent protein after
silver staining, and Western blotting confirmed that the
recombinant protein was reactive with MAb 3B9.22A
(data not shown).
When cell adhesion assays were carried out, CV-1
cells attached to wells coated with purified ppM44 in a
concentration-dependent manner (Fig. 7A), and adhesion
was inhibited by the presence of RGD peptides (Fig. 7B).
Thus our data suggested that ppM44 synthesized in an
eukaryotic expression system could mediate cell adhe-
sion in a similar manner.
RGD-to-RGE mutation does not affect association with
the MCMV polymerase catalytic subunit pM54 (pol)
Although the RGD tripeptide is primarily known as a
cell adhesion motif present in substrates that mediate
integrin binding, a recent report demonstrated that the
motif is required for the interaction between the f29
FIG. 6. Purified HCMV UL44 protein, but not HHV-6 p41, could
mediate adhesion of CV-1 cells. (A) Cell adhesion assays were carried
out with wells of PolySorp plates coated with different concentrations of
purified histidine-tagged UL44 or p41 proteins in the presence of 0.25
M urea as described under Materials and Methods. Optical density
readings at 600 nm (OD600) were used to quantify the amount of
toluidine blue stain extracted from adherent cells. (B) Cell adhesion
assays were carried out in wells coated with 100 ml of purified UL44
protein at 7.5 mg/ml in the presence of RGD or RGE peptides, EDTA, or
MEM only (control). The “BSA” wells were coated with only bovine
erum albumin. Optical density readings at 600 nm (OD600) were usedto quantify the amount of toluidine blue stain extracted from adherent
cells.
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307RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEINterminal protein and DNA polymerase (Illana et al., 1998).
his prompted us to investigate whether the conserved
GD motif is required for the specific association of
pM44 with pM54, the polymerase catalytic subunit. Be-
ause ppM44 often coprecipitated with multiple viral
roteins in MCMV-infected cells (Loh et al., 1991, 1994),
e decided to use a GST pull-down assay to examine
he direct interaction between ppM44 and pM54.
As shown in Fig. 8A, with GST-pol as bait in a GST
ull-down assay, both ppM44 (lane 2) and the mutant
pM44D278E (lane 5) were able to interact with pM54,
he polymerase catalytic subunit. Conversely, as shown
n Fig. 8B, pM54 synthesized in an in vitro translation
reaction interacted with both GST fusion proteins (GST-
M44 in lane 2 and GST-M44D278E in lane 5). Thus a
D-to-E substitution in the RGD motif did not appear to
significantly affect the interaction between ppM44 and
pM54. The conserved RGD motif did not play an essen-
FIG. 7. Purified M44 protein produced in a vaccinia/T7 expression
system can mediate adhesion of CV-1 cells. (A) Cell adhesion assays
were carried out with wells of PolySorp plates coated with different
concentrations of purified histidine-tagged M44 protein as described
under Materials and Methods. Optical density readings at 600 nm
(OD600) were used to quantify the amount of toluidine blue stain ex-
tracted from adherent CV-1 cells. (B) Cell adhesion assays were carried
out in wells coated with 100 ml of purified M44 protein at 10 mg/ml in the
presence of RGD or RGE peptides or DMEM only (control). The “BSA”
wells were coated with only bovine serum albumin. Optical density
readings at 600 nm (OD600) were used to quantify the amount of
toluidine blue stain extracted from adherent cells.tial role in the interaction between the polymerase sub-
units.
t
appM44 is present in the culture media
of MCMV-infected cells
If the ability of ppM44 to mediate integrin binding plays
a role in MCMV infection, the viral protein would likely
have to be present outside the cell to interact with inte-
grin molecules on the cell surface. Thus we monitored
the accumulation of ppM44 outside MCMV-infected cells
by using the ppM44-specific MAb 3B9.22A to immuno-
precipitate the viral protein from culture media collected
28 h postinfection. The results are shown in Fig. 9A. As
expected, ppM44 was abundantly precipitated from in-
fected cells as a prominent 50K band (lane 4). Interest-
ingly, ppM44 was also immunoprecipitated from the “su-
pernatant” and “filtered supernatant” fractions of the cul-
ture media (defined under Materials and Methods), albeit
at much lower amounts (lanes 5 and 6). This was espe-
cially true regarding the filtered supernatant, where
larger protein aggregates were likely removed along with
MCMV virions. For comparison purposes, immunopre-
cipitations were carried out in parallel with MAb
9D3.22A, which recognizes an epitope present on sev-
eral nuclear proteins derived from the e1 transcription
unit (Bu¨hler et al., 1990). Although E1 proteins were
readily immunoprecipitated from infected cells (Fig. 9A,
lane 1), no immunoprecipitated proteins were detectable
in either the supernatant or the filtered supernatant frac-
tions (lanes 2 and 3). At this point, we have no evidence
that ppM44 is actively transported out of infected cells.
However, the abundance of ppM44 relative to the E1
proteins in MCMV-infected cells makes it likely that
larger quantities of this viral protein could be released
into the culture medium upon cell lysis late in infection,
FIG. 8. An aspartic acid-to-glutamic acid mutation in the RGD se-
quence does not affect association of ppM44 with pM54. (A) GST (lanes
3 and 6) and GST-pol (lanes 2 and 5) fusion proteins were incubated
with equivalent amounts of [35S]-methionine-labeled wt M44 (lanes 1–3)
and mutant M44D278E proteins (lanes 4–6) synthesized in in vitro
translation reactions in GST pull-down assays. One tenth of the input
protein target (lanes 1 and 4) and proteins bound to glutathione–
Sepharose beads were analyzed by 7.5% SDS–PAGE and visualized by
autoradiography. (B) GST (lanes 3 and 6) and GST fusion proteins with
wt M44 (lane 2) or mutant M44D278E (lane 5) were incubated with
equivalent amounts of [35S]-methionine-labeled pM54 (labeled pol) syn-
thesized in an in vitro translation reaction in GST pull-down assays.
ne tenth of the input protein target (lanes 1 and 4) and proteins bound
o glutathione–Sepharose beads were analyzed by 7.5% SDS–PAGE
nd visualized by autoradiography.
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308 LOH ET AL.thereby making ppM44 more readily detectable than the
E1 proteins.
To further explore this possibility, we followed the fate
of ppM44 synthesized in infected cells in a series of
pulse-chase experiments as described under Materials
and Methods. Because of the relatively small amount of
ppM44 present in the supernatant fraction, MCMV-in-
fected cells were radiolabeled for 2 h to ensure detection
by autoradiography within 1 week. Results from our im-
munoprecipitation experiments were very similar regard-
less of whether the infected cells were radiolabeled
18–20, 28–30, or 39–41 h postinfection. Therefore, only
one set of data is shown (Fig. 9B). During the 2-h labeling
FIG. 9. ppM44 was detectable in culture medium of MCMV-infected
cells. (A) Balb/3T3 fibroblasts infected with MCMV at an m.o.i. of 10
were radiolabeled with [35S]-methionine (50 mCi/ml) from 14 to 28 h
ostinfection when cells were solubilized in Tris-buffered saline sup-
lemented with 1% Nonidet P-40 and 1% deoxycholate. Culture medium
as collected and processed as “supernatant” and “filtered superna-
ant” fractions as described under Materials and Methods. Proteins
mmunoprecipitated from one tenth of the infected cell extracts (lanes
and 4), one fourth of the “supernatant” fraction (lanes 2 and 5), or one
ourth of the “filtered supernatant” fraction (lanes 3 and 6) by MAbs
D3.22A (lanes 1–3) and 3B9.22A (lanes 4–6) were analyzed by 9%
DS–PAGE and visualized by autoradiography. (B) Balb/3T3 fibroblasts
nfected with MCMV at an m.o.i. of 10 were radiolabeled at 18 h
ostinfection for 2 h with [35S]-methionine and chased for 2 or 8 h as
escribed under Materials and Methods. Immunoprecipitation reac-
ions with MAb 3B9.22A were carried out with cell lysates (lanes 2, 4,
nd 6) and supernatants (lanes 1, 3, and 5) harvested immediately after
ither the labeling period (“pulse”) or the indicated chase periods.
ypically, one twentieth of the cell lysate and the entire supernatant
raction harvested at each time point were used. Immunoprecipitated
roteins were analyzed by 7.5% SDS–PAGE and visualized by autora-
iography.period, ppM44 was found exclusively in the cellular frac-
tion (compare lanes 1 and 2). Although the viral protein
p
swas still predominantly found inside infected cells during
chase periods of up to 8 h, ppM44 was clearly detectable
by immunoprecipitation in the surrounding culture me-
dium (lanes 3–6). Based on the intensities of the immu-
noprecipitated ppM44 bands and the amount of sample
(cellular or supernatant fractions) used for the precipita-
tion reactions, we estimated that extracellular ppM44
constituted no more than 0.5–1% of the total amount of
ppM44 synthesized during the labeling period. Under the
conditions of infection in these experiments (m.o.i. 5 10),
a significant accumulation of intracellular ppM44 began
around 18 h postinfection. Measurements of the viability
and membrane integrity of infected cells by trypan blue
exclusion suggested that cell lysis occurred in 2–3% of
these cells at 18–30 h postinfection and increased rap-
idly beyond 10% by 42 h postinfection (Loh et al., manu-
script in preparation). Therefore, although our data did
not exclude the possibility of ppM44 being actively trans-
ported outside infected cells, they were consistent with
the idea that during the late phase of MCMV infection,
small amounts of ppM44 are released into the culture
medium upon lysis of infected cells.
DISCUSSION
In this report, we provided evidence that MCMV
ppM44 could mediate cell adhesion by acting as a sub-
strate for integrin binding. First, structural predictions
based on sequence analysis of the M44 ORF revealed
that the RGD sequence is likely located at a b turn (Chou
nd Fasman, 1978) near the C-terminal of the highly
onserved region 2 (Fig. 1). Moreover, the same motif is
reserved in the HCMV UL44 ORF, raising the possibility
hat the motif may play a novel role in CMV infection.
owever, the presence of an RGD motif alone does not
uarantee cell adhesive activity because flanking se-
uences often influence its conformation and the avail-
bility of appropriate integrin receptor molecules on the
ell surface also affects the final outcome (Piersch-
acher and Ruoslahti, 1984). For example, entactin–nido-
en mediates RGD-dependent adhesion rather poorly by
tself, often requiring incubation periods of 2–3 h, but
idogen–laminin complexes bind cells with high affinity
Mann et al., 1989). Meanwhile, laminin can mediate both
GD-dependent and RGD-independent cell adhesion by
inding to b3 and b1 integrin subunits, respectively, via
ts P1 and E8 fragments (Sonnenberg et al., 1990). Inter-
stingly, cell adhesion to collagen I can be inhibited only
y GRGDTP peptides, not GRGDSP peptides (Dedhar et
l., 1987), suggesting that flanking amino acid residues
ffect the binding capacity of the RGD motif.
Our data on CV-1 adhesion mediated by the substrates
escribed above were consistent with these findings
Fig. 3). By using purified histidine-tagged M44 protein
roduced either in E. coli or the vaccinia/T7 expression
ystem in cell adhesion assays, we demonstrated that
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309RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEINthe viral protein could mediate cell attachment in a man-
ner characteristic of integrin binding. For example, cell
adhesion was abolished in the presence of EDTA and
competing RGD peptides. Thus among the substrates
tested, the adhesive property of ppM44 bears the most
similarity to that of fibronectin (Fig. 3). The fact that
recombinant M44 protein produced in either prokaryotic
or eukaryotic systems was able to mediate integrin bind-
ing suggested that the additional posttranslational mod-
ifications present in the latter system were probably not
required for the activity.
A BLASTP search (Altschul et al., 1997) of known
CMV and MCMV ORFs revealed that the RGD motif is
resent in two other HCMV proteins [the UL102 (Smith
nd Pari, 1995) and the UL83 (Ruger et al., 1987) gene
roducts] as well as three additional MCMV proteins [the
c receptor fcr 1 (Tha¨le et al., 1994), the major DNA-
inding protein (MDBP) (Messerle et al., 1992), and an
ncharacterized ORF (Rawlinson, 1996; accession num-
er AAA58341)]. Even though none of these proteins
ave been tested for cell-binding activity, their RGD mo-
ifs are not conserved between CMV homologs. Unpub-
ished work from our laboratory indicated that MCMV
DBP was made in quantities significantly lower than
pM44 during infection and was not detectable extracel-
ularly under the circumstances described in this report.
Most of the cell adhesion assays were carried out with
ecombinant proteins produced in bacteria. Because the
rotein accumulated primarily in the insoluble pellet,
hich was solubilized in 6 M urea and allowed to refold
uring dialysis and the removal of urea, it could be
rgued that the resulting protein may assume a confor-
ation different from that of authentic ppM44. Further-
ore, the addition of a 6x histidine tag may have an
ffect on protein conformation as well. Several lines of
vidence suggested that the recombinant protein could
efold in a manner similar to authentic ppM44, at least
round conserved region 2, where the RGD motif is
ocated. First, we observed that the histidine-tagged
pM44 expressed in the vaccinia/T7 expression system
as localized exclusively to the nuclei of infected cells
data not shown). Moreover, we have found that the
istidine-tagged M44 protein synthesized in an in vitro
ranslation reaction possessed DNA-binding activity sim-
lar to that of the unmodified protein (our unpublished
esults). Because both of these properties are dependent
n the integrity of the highly conserved N-terminal do-
ain (Loh et al., 1999), it is likely that the addition of the
istidine residues did not significantly alter the confor-
ation of the protein. Second, the cell adhesion activity
f the histidine-tagged M44 protein was abolished by a
ingle amino acid substitution (Fig. 5), suggesting that
he histidine tag is not required for cell adhesion. Third,
monoclonal antibody (9A5) that recognizes a confor-
ation-dependent epitope sensitive to alterations within
egion 2 (Loh et al., 1999) is reactive with both the
n
irefolded, histidine-tagged M44 or mutant M44D278E pro-
teins (Table 1), suggesting that the recombinant M44
protein is probably folded correctly in region 2 where the
RGD sequence is located. Finally, the histidine-tagged
ppM44 produced in the vaccinia/T7 expression system
was maintained in a soluble form throughout the purifi-
cation procedures and the cell adhesion experiments,
implying that the native conformation of the protein is
likely preserved. Thus it is worth noting that the cell
adhesion activity of the M44 protein produced in this
eukaryotic expression system is quite similar to that of
the M44 protein produced in bacteria (Figs. 3 and 7),
providing evidence that the latter has probably refolded
to a conformation similar to that of the authentic ppM44.
Nevertheless, we also found that the cell adhesion ac-
tivity leveled off at a lower level when the recombinant
protein was diluted in PBS supplemented with 0.25 M
urea before the cell adhesion assay (Figs. 5 and 6),
suggesting that although the presence of urea helps to
maintain ppM44 in a soluble form, it may have a slightly
detrimental effect by affecting either protein conforma-
tion or absorption of the recombinant protein onto the
wells.
We noted that ppM44 was detectable in the culture
media during MCMV infection (Fig. 9), albeit in small
amounts. Because we have previously demonstrated
that ppM44 is not a component of the MCMV virion (Loh
et al., 1991), the extracellular ppM44 must be derived
from protein synthesized during MCMV infection. We
have observed that significant accumulation of ppM44 (a
delayed-early protein) in infected cells did not occur until
18 h postinfection (Loh et al., manuscript under prepara-
tion) and newly synthesized ppM44 could be detected in
the supernatant fraction after a 2-h or longer chase
period (Fig. 9B). Without excluding the possibility of
ppM44 being actively transported outside the cell, our
results are compatible with a scenario in which the
presence of ppM44 in the media could be explained by
the lysis of 1–2% of virus-infected cells during the first
36 h of MCMV infection. Nevertheless, it remains likely
that ppM44 may be present locally in sufficient amounts
around infected cells to bind to cell surface integrin
molecules. Because recombinant HCMV UL44 protein
could also mediate cell adhesion, and hence integrin
binding activity, some of our speculations here may apply
to HCMV infection as well. A review of earlier publica-
tions regarding the characterization of monoclonal anti-
bodies specific for MCMV M44 or HCMV UL44 proteins
provided some support for the presence of these pro-
teins on the cell surface. For example, the UL44-specific
MAb CH16 was initially characterized as recognizing a
viral antigen on the surface of unfixed cells infected with
HCMV (Pereira et al., 1982). In addition, our laboratory
as reported that the MAb 5H10.21A was able to immu-
oprecipitate ppM44 from MCMV-infected cells surface
odinated with lactoperoxidase (Loh et al., 1991), al-
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310 LOH ET AL.though subsequent attempts to isolate ppM44 from
membrane fractions of infected cells have been unsuc-
cessful. Given the weak interactions between integrins
and their RGD-bearing substrates, it is possible that
conventional biochemical methods of purification could
disrupt the interactions between ppM44 and integrins.
However, these earlier observations do provide some
support for our conjecture that ppM44, and possibly
ppUL44, could be present on the cell surface as a result
of binding to integrin molecules via their conserved RGD
sequences. Assuming that authentic ppM44 is released
into the culture media upon cell lysis and is capable of
binding to cell surface integrin molecules, one can spec-
ulate that it may play a role in CMV infection in vivo. One
intriguing possibility is that binding of extracellular
ppM44 or ppUL44 to cell surface integrins may activate
intracellular signaling pathways involved in cell cycle
progression and cell survival. For example, integrins can
activate the Ras-extracellular signal-regulated kinase
(ERK), MAPK cascade through its involvement in the FAK
and Fyn/Shc pathways (Giancotti and Ruoslahti, 1999),
and a recent report indicated that activation of ERKs
appears to be important for early gene expression (Ro-
dems and Spector, 1998). The ppM44–integrin associa-
tion may also partially compensate for the loss of inte-
grin–extracellular matrix interaction (and cell attachment)
as a result of virus infection and prolongs cell survival.
Thus the interaction of ppM44 or ppUL44 with integrins
could potentially influence the course of CMV infections.
These possibilities will require further experimentation in
ivo.
MATERIALS AND METHODS
irus and cells
The Vancouver strain of MCMV (Boname and Chantler,
992) was originally obtained from Dr. J. B. Hudson of the
niversity of British Columbia and propagated in this
aboratory in 3T3-L1 cells. Virus titers were quantified by
laque assays on Balb/3T3 cells [CCL163; American
ype Culture Collection (ATCC), Rockville, MD]. Recom-
inant vaccinia virus stably expressing the bacterio-
hage T7 RNA polymerase (VV-T7) was a gift from Dr.
illiam Britt (University of Alabama). The virus was prop-
gated and quantified by plaque assays in CV-1 cells
ATCC CCL70). Both CV-1 and Balb/3T3 cells were main-
ained in Dulbecco’s modified Eagle’s medium (DMEM)
upplemented with 10% fetal bovine serum and pas-
aged according to conditions specified by ATCC.
Harvesting of MCMV-infected cells radiolabeled with
35S]-methionine was performed as previously described
Loh et al., 1991). The resulting lysate contained infected
ell proteins. To monitor viral proteins accumulated in
he culture medium, the following additional steps were
ollowed. After MCMV-infected cells were radiolabeled
rom 14–28 h postinfection, the culture medium wasollected and centrifuged at 15,000 g in a microfuge for
min to remove cellular debris. The clarified culture
edium was labeled the “supernatant” fraction. This frac-
ion was then filtered through a 22-mm filter to remove
nsoluble protein aggregates, and virtually all the MCMV
irions still present. The filtered medium contained less
han 1 plaque-forming unit (pfu)/ml of infectious virus as
etermined by plaque assays and was labeled the “fil-
ered supernatant” fraction.
To assess the time of appearance of ppM44 in the
ulture media, Balb/3T3 fibroblasts infected with MCMV
t a multiplicity of infection (m.o.i.) of 10 were radiola-
eled with [35S]-methionine (250 mCi/ml) for 2 h in me-
thionine-free medium at 18, 28, and 39 h postinfection.
Infected cells and supernatants were harvested either
immediately or after a chase period of 2–8 h in the
presence of 10 times the normal concentrations of me-
thionine. The amount of ppM44 present in the cellular or
supernatant fractions was estimated by immunoprecipi-
tation with the ppM44-specific MAb 3B9.22A.
Monoclonal antibodies
Monoclonal antibodies used in this report have been
described previously. In particular, MAb 9A5 was raised
against HHV-6 p41 (Chang and Balachandran, 1991) but
also recognized a conformation-dependent epitope on
ppM44 (Loh et al., 1999). MAb 3B9.22A was reactive with
a linear epitope located within the C-terminal tail of
ppM44 (Loh et al., 1991, 1999). MAb 9D3.22A recognized
an epitope present on several proteins derived from the
e1 transcription unit. Finally, MAb 28-21 was specific for
the HCMV UL44 gene product (Britt and Vulger, 1987).
Site-directed mutagenesis
The QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA) was used to convert an
aspartic acid (GAC) at residue 278 of the M44 ORF to
a glutamic acid (GAG, underlined in the primer se-
quences shown) using a pair of complementary mu-
tagenesis primers CGTGCGCGGCGAGGTGGGCTTT-
GAC and GTCAAAGCCCACCTCGCCGCGCACG. The
plasmid TB16N (Loh et al., 1999), which contains the
entire M44 ORF, was used as the template for the
mutagenesis reaction. Plasmid DNAs from eight inde-
pendently selected clones were sequenced to verify
that the G-to-C conversion was successful and that no
other changes in the M44 ORF were made. The result-
ing plasmid was labeled TB16N-D278E.
Plasmid constructs
To facilitate the expression and purification of the wt or
mutant M44 gene product in E. coli, the entire ORF of
M44 was excised as a 1.6-kb NcoI–HindIII DNA fragment
from the plasmids TB16N or TB16N-D278E and cloned
into compatible restriction sites of the plasmid pRsetB
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311RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEIN(InVitrogen, San Diego, CA) to produce pRsetBpp50 or
pRsetBpp50D278E, respectively. In both cases, the M44
ORF was fused in-frame with six histidine residues that
provide a tag for purification by metal chelation affinity
chromatography. In addition, expression of the fusion
protein was placed under the control of the bacterio-
phage T7 promoter. Furthermore, unique BglII, KpnI, and
BamHI sites on the cloning vector are now located di-
rectly upstream of the M44 ORF. Bacteria [E. coli strain
BL21(DE3)] harboring these expression plasmids were
used for the production of histidine-tagged M44 proteins.
The PCR was used to amplify the coding sequences
for HCMV UL44 and HHV-6 p41 from genomic DNA and
cDNA clones kindly provided by Drs. W. Britt and B.
Chandran. The primers were designed to provide a
unique BamHI site as well as an NcoI site just upstream
and a unique HindIII site just downstream from both
ORFs. The upper and lower primers for amplifying the
UL44 ORF were GCTGGGATCCATGGATCGCAAGAC and
GGCCCAAGCTTTAGCCGCACTT, respectively. The upper
and lower primers for amplifying the p41 ORF were
TGGGATCCATGGAGCGCGGTAGTC and CGGCAAGCT-
TAGCAAGACCGAGAATA, respectively. The proofreading
pfu polymerase (Stratagene) was used in the PCRs to
minimize amplification errors, and nucleotide sequenc-
ing was carried out to verify that no other nucleotide
changes were introduced into both ORFs. The amplified
UL44 DNA was cleaved with BamHI and HindIII and
inserted into RsetB between the BglII and HindIII sites to
reate the plasmid pRsetB-UL44. Similarly, the amplified
41 DNA was cleaved with NcoI and HindIII and cloned
nto compatible sites of RsetB to create the plasmid
RsetB-p41N. In both instances, the viral coding se-
uences were fused in-frame with six histidine residues
o facilitate purification by metal chelation affinity chro-
atography.
To carry out glutathione-S-transferase (GST) pull-down
ssays, we inserted the 1.3-kb BglII–SmaI fragment from
RsetBpp50 or pRsetBpp50D278E between the BamHI–
maI sites of the plasmid vector pGEX-4T-1 (Pharmacia)
o create the plasmids pGEXpp50 and pGEXpp50D278E,
espectively. Thus the entire M44 ORF was fused in-
rame with the GST coding sequences present in the
ector. The E. coli strain DH5a was transformed with the
GEX plasmids so that on induction with IPTG, the fusion
rotein GST-M44 or GST-M44D278E would be overpro-
uced.
The insertion of the MCMV M54 ORF, which encodes
he polymerase catalytic subunit (Rawlinson et al., 1996;
lliot et al., 1991) into the pGEX-4T-1 vector, was accom-
lished as follows. The 59 end of the M54 ORF was
mplified by PCR from the plasmid pOPRSV1/pol (a gift
rom Dr. D. H. Spector, University of California, San Di-
go) using the upper and lower primers GTACTGACG-
CCGCCATGGACACTT and GACGCCGAAACAGACG-
CAGGAGAT, thereby creating a NcoI site (underlined) atthe translation start site of the M54 ORF. The amplified
DNA was cleaved with NcoI and SalI to generate a
.92-kb fragment. The 39 end of the M54 ORF was ex-
cised as a 2.5-kb fragment from pOPRSV1/pol by cutting
with SalI and MseI, with the latter site filled in by treat-
ment with the Klenow fragment of DNA polymerase I. The
entire M54 ORF was reconstituted by inserting the
0.92-kb NcoI–SalI fragment and the 2.5-kb SalI–MseI
(filled-in) fragment into the vector pCITE-2b (Novagen)
cut with NcoI and BglII, with the single-stranded ends of
the BglII site filled in by treatment with the Klenow frag-
ment of DNA polymerase I. The newly created plasmid
pCITEpol would contain a unique XbaI site downstream
from the M54 ORF. Then the 3.4-kb DNA fragment con-
taining the M54 ORF was excised with NcoI and XbaI,
and the single-stranded ends were filled in with the
Klenow fragment of DNA polymerase I. Similarly, pGEX-
4T-1 was cut with EcoRI and NotI, with the single-
tranded ends filled in. Finally, the 3.4-kb fragment was
nserted into the vector to create pGEXpol, thereby plac-
ng the M54 ORF in-frame with the GST coding se-
uences. The E. coli strain BL21(DE3) was transformed
ith pGEXpol for the production of the GST-pol fusion
rotein.
etal chelation affinity column chromatography
For production of viral protein in bacteria, E. coli
strain BL21(DE3)] harboring plasmids (pRsetBpp50,
RsetBpp50D278E, pRsetB-UL44, and pRsetB-p41N) en-
oding histidine-tagged fusion proteins were grown in
00-ml cultures (L-broth containing ampicillin at 50 mg/
ml) and induced with IPTG (0.8 mM) at an OD600 (optical
density at 600 nm) between 0.5 and 0.7. Bacteria were
harvested 3 h later, solubilized in lysis buffer (50 mM
Tris–HCl, pH 8.0, 2 mM EDTA, 0.1% Triton X-100, and
lyzosyme at 100 mg/ml), sonicated briefly, and clarified by
centrifugation. The insoluble pellets were generally
washed in 1.5 M urea, solubilized in 6 M urea, and
dialyzed against decreasing concentrations of urea in a
stepwise fashion (4, 2, 1, 0.5, and 0.25 M). To facilitate
refolding of the solubilized recombinant protein, we
waited at least 4 h before each change of buffer. The
histidine-tagged fusion proteins were further purified by
His*Bind affinity purification resin according to manufac-
turer’s instructions (Novagen, Madison, WI). In most ex-
periments, column purification was carried out in the
absence of urea, and the eluted protein was stored and
diluted in PBS for cell adhesion assays. We found that
when the concentration of the recombinant protein ex-
ceeded 100 mg/ml, the proteins have a tendency to
precipitate in the column. Therefore, as indicated in se-
lected experiments, the solutions used during column
purification were supplemented with 0.25 M urea to
maintain the solubility of the protein during the purifica-
tion procedure. Proteins in the eluted fractions were
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312 LOH ET AL.analyzed by SDS–PAGE and visualized by silver staining
to estimate the amount and purity of the histidine-tagged
protein. Finally, the identity of the eluted protein was
verified by Western blotting with an appropriate mono-
clonal antibody. MAbs 3B9.22A, 28-21, and 9A5 were
used to detect the presence of MCMV M44, HCMV UL44,
and HHV-6 p41, respectively. In general, the first two
eluted fractions were pooled, and the protein contents
were quantified by the Bio-Rad (Hercules, CA) protein
assay according to the manufacturer’s instructions.
The vaccinia/T7 expression system (Fuerst et al., 1986)
was used to produce sufficient amount of histidine-
tagged ppM44 in a eukaryotic system for adhesion as-
says. Briefly, CV-1 cells were transfected with pRset-
Bpp50 and allowed to attach to tissue culture plates for
4 h before infection with VV-T7 at a multiplicity of infec-
tion of 5. Infected cells were harvested 2 days later when
extensive cytopathic effect was evident. Briefly, cells
were washed with cold PBS and lysed in PBS supple-
mented with 0.5 M NaCl, 0.5% Nonidet P-40, and 0.5%
deoxycholate. The solubilized infected cell proteins were
diluted fivefold with binding buffer and applied to a col-
umn containing charged His*Bind resin preequilibrated
with binding buffer. The histidine-tagged ppM44 was
then purified as described earlier.
Cell adhesion assays
Cell adhesion assays were performed essentially as
described by Bai et al. (1993) with some modifications.
The RGD-containing proteins fibronectin, collagen I,
laminin 1, and entactin were purchased from Aldrich
Canada, whereas the histidine-tagged M44 protein was
purified as described earlier. Briefly, serial dilutions of
purified protein were made in PBS. In instances where
the recombinant protein was already solubilized in PBS
supplemented with 0.25 M urea, the same solution was
used for dilutions to prevent the precipitation of the
purified protein. Then, each well of a PolySorp (Nunc)
96-well plate was coated overnight at 4°C with 100 ml of
the protein at defined concentrations. In the morning, the
wells were washed twice with 200 ml of PBS and blocked
ith BSA (10 mg/ml in PBS, 100 ml/well) for 2 h at 4°C.
Subsequently, the wells were washed once with PBS and
once with warm DMEM in preparation for the addition of
adherent cells.
Freshly trypsinized cells (CV-1 or Balb/3T3 fibroblasts)
were washed extensively in DMEM and resuspended in
DMEM at a concentration of 2 3 106 cells/ml. Fifty mi-
croliters of cells mixed with an equal volume of either
DMEM or peptides dissolved in DMEM was then added
to each well and incubated at 37°C in an atmosphere of
5% CO2 for 1 h. The “RGD” (amino acid sequence,
GRGDSP) and “RGE” (amino acid sequence, GRGESP)
peptides used in this report were purchased from GIBCO
BRL (Grand Island, NY). Afterward, the wells werewashed eight times with 200 ml of PBS to remove unat-
tached cells. Adherent cells were then fixed with 100 ml
f 4% formaldehyde (in PBS) for 30 min at room temper-
ture and stained with 0.5% toluidine blue in 4% formal-
ehyde–PBS for 15 min. Wells were again washed ex-
ensively with PBS. Cell-associated stain was extracted
ith 200 ml of methanol per well for 15 min and quantified
y measuring the optical density at 600 nm (OD600). All
ssays were conducted in quadruplicate, and the OD600
values shown in the graphs represent the mean of these
four determinations and the standard deviations (error
bars). Although the data were not shown in all the
graphs, wells coated with appropriate amounts of fi-
bronectin were used as positive controls in virtually all
cell adhesion experiments to ensure that the assays
were carried out properly.
ELISAs
Wells of a 96-well plate were each coated with 100 ml
f recombinant protein at appropriate concentrations
vernight at 4°C. All subsequent manipulations were
arried out at room temperature. The next morning, wells
ere washed extensively with PBS to remove unbound
rotein and blocked with 100 ml/well BSA at a concen-
tration of 10 mg/ml for 2 h. Next, they were incubated
with monoclonal antibodies [usually diluted 1:5000 in
Tris-buffered saline supplemented with 0.025% Tween 20
(TBST)] specific for the bound protein for 1 h, washed
four times with TBST, and incubated with goat anti-
mouse antibody conjugated with alkaline phosphatase
(Bio-Rad, diluted 1:5000 in TBST) for an additional hour.
The wells were then washed four times with TBST and
once with TBS. Finally, the alkaline phosphatase sub-
strate p-nitrophenyl phosphate (Bio-Rad alkaline phos-
phatase substrate kit) was added, and the reaction was
allowed to proceed until color was visible in the positive
wells. The reactivity was quantified by measuring the
optical density at 405 nm.
GST pull-down assay
GST fusion proteins were produced as follows. E. coli
[strain BL21(DE3)] harboring plasmids encoding GST-
M44 fusion proteins (pGEXpp50, pGEXpp50D278E) were
grown in 250-ml cultures (23 YT supplemented with 2%
glucose) and induced with IPTG (0.8 mM) at an OD600
between 0.5 and 0.6. Bacteria were harvested 3 h later,
solubilized in lysis buffer (50 mM Tris–HCl, pH 8.0, 2 mM
EDTA, 0.1% Triton X-100, and lyzosyme at 100 mg/ml),
sonicated briefly, and clarified by centrifugation. For E.
coli harboring the plasmid pGEXpol, bacterial cultures
were switched to 30°C after IPTG induction and grown
for at least 4 h before harvesting to increase the amount
of soluble GST-pol fusion protein available for purifica-
tion. GST fusion proteins present in the soluble fractions
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313RGD SEQUENCE IN CMV DNA POLYMERASE ACCESSORY PROTEINwere purified on glutathione–Sepharose 4B beads (Phar-
macia) according to the manufacturer’s instructions.
Our protocol for GST pull-down assays was based on
that described by Misra et al. (1995) except that 0.5 M
NaCl was used in the wash buffers to reduce nonspecific
binding. [35S]-Methonine-labeled target proteins were
synthesized in a TNT T7-coupled reticulocyte lysate sys-
tem (Promega, Madison, WI) as previously described
(Loh et al., 1994). The amount of GST fusion protein
bound to glutathione–Sepharose beads was estimated
by the intensity of the protein band stained by Coomas-
sie blue, and the volume of beads used in each pull-
down reaction was adjusted accordingly. Radiolabeled
target proteins interacting with GST fusion proteins were
separated by SDS–PAGE and visualized by autoradiog-
raphy.
Gel electrophoresis, immunoprecipitation, and
Western blotting
SDS–PAGE and detection of viral proteins by immuno-
precipitation or Western blotting were carried out as
previously described (Loh et al., 1991). Purified proteins
were often visualized by staining with a Bio-Rad silver
stain kit according to the manufacturer’s instructions.
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